Location History:
- Arlington, MA (US) (2016)
- Belmont, MA (US) (2017)
Company Filing History:
Years Active: 2016-2017
Title: The Innovative Mind of Eduard Luss-Lusis: Transforming Cystic Fibrosis Treatment
Introduction
Eduard Luss-Lusis, based in Belmont, MA, is an accomplished inventor with a focus on advancing therapeutic solutions for cystic fibrosis. With a total of two patents to his name, Luss-Lusis is making significant strides in the field of pharmaceutical science.
Latest Patents
Eduard Luss-Lusis holds two notable patents. The first is related to co-crystals of modulators of the cystic fibrosis transmembrane conductance regulator. This innovation encompasses co-crystals comprising N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (Compound 1) alongside a co-former, along with methods for their preparation. The patent further elaborates on pharmaceutical compositions containing these co-crystals, as well as their applications in treatment and related kits. His second patent involves modulators of ATP-binding cassette transporters, which describes compounds proven useful as modulators of ABC transporters or fragments thereof, including the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR). This invention includes methods for treating diseases mediated by ABC transporters using these novel compounds.
Career Highlights
Eduard Luss-Lusis is currently employed at Vertex Pharmaceuticals, Inc., a leading biopharmaceutical company dedicated to advancing innovative therapies for serious diseases. His work primarily focuses on developing solutions aimed at improving the lives of patients suffering from cystic fibrosis.
Collaborations
Throughout his career, Luss-Lusis has had the opportunity to collaborate with talented professionals in the industry, including notable coworkers Adam R. Looker and Benjamin Joseph Littler. These collaborations have undoubtedly enriched his research and contributed to the development of his innovative patents.
Conclusion
In summary, Eduard Luss-Lusis stands out as an influential inventor whose contributions in the pharmaceutical field, particularly in relation to cystic fibrosis, are paving the way for new treatment modalities. His innovative approach, paired with collaboration, underlines the importance of teamwork in achieving breakthroughs that can significantly impact patient outcomes.